Farhana Islam
0000-0003-4800-0723
University of Toronto
12 papers found
Refreshing results…
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND ‐1 Study
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis
Pharmacogenetics‐Guided Advances in Antipsychotic Treatment
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia
Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine
Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions
Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia
Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference
Missing publications? Search for publications with a matching author name.